Global Live Attenuated Measles Vaccine Production, Demand and Key Producers, 2022-2028
This report studies the global Live Attenuated Measles Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Live Attenuated Measles Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Live Attenuated Measles Vaccine that contribute to its increasing demand across many markets.
The global Live Attenuated Measles Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Live Attenuated Measles Vaccine total production and demand, 2017-2028, (K Units)
Global Live Attenuated Measles Vaccine total production value, 2017-2028, (USD Million)
Global Live Attenuated Measles Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Live Attenuated Measles Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Live Attenuated Measles Vaccine domestic production, consumption, key domestic manufacturers and share
Global Live Attenuated Measles Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Live Attenuated Measles Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Live Attenuated Measles Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Live Attenuated Measles Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Live Attenuated Measles Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Live Attenuated Measles Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Live Attenuated Measles Vaccine Market, By Region:
1. How big is the global Live Attenuated Measles Vaccine market?
2. What is the demand of the global Live Attenuated Measles Vaccine market?
3. What is the year over year growth of the global Live Attenuated Measles Vaccine market?
4. What is the production and production value of the global Live Attenuated Measles Vaccine market?
5. Who are the key producers in the global Live Attenuated Measles Vaccine market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Live Attenuated Measles Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Live Attenuated Measles Vaccine that contribute to its increasing demand across many markets.
The global Live Attenuated Measles Vaccine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Live Attenuated Measles Vaccine total production and demand, 2017-2028, (K Units)
Global Live Attenuated Measles Vaccine total production value, 2017-2028, (USD Million)
Global Live Attenuated Measles Vaccine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Live Attenuated Measles Vaccine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Live Attenuated Measles Vaccine domestic production, consumption, key domestic manufacturers and share
Global Live Attenuated Measles Vaccine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Live Attenuated Measles Vaccine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Live Attenuated Measles Vaccine production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Live Attenuated Measles Vaccine market based on the following parameters – headquarters, production locations, products portfolio, Live Attenuated Measles Vaccine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Live Attenuated Measles Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Live Attenuated Measles Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Liquid
- Powder
- Hospital
- Clinic
- GSK
- Sanofi-Pasteur
- Merck
- Pfizer
- Serum Institute of India
- Novartis
- Emergent Biosolutions
- Bavarian Nordic
- Medimmune
- Johnson & Johnson
- CSL Limited
- Changchun Qijian Biological Products Co., Ltd
- Beijing Institute of Biological Products Co., Ltd
- Wuhan Institute of Biological Products Co., Ltd
- Shanghai Institute of Biological Products Co., Ltd
- Lanzhou Institute of Biological Products Co., Ltd
1. How big is the global Live Attenuated Measles Vaccine market?
2. What is the demand of the global Live Attenuated Measles Vaccine market?
3. What is the year over year growth of the global Live Attenuated Measles Vaccine market?
4. What is the production and production value of the global Live Attenuated Measles Vaccine market?
5. Who are the key producers in the global Live Attenuated Measles Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Live Attenuated Measles Vaccine Introduction
1.2 World Live Attenuated Measles Vaccine Supply & Forecast
1.2.1 World Live Attenuated Measles Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Live Attenuated Measles Vaccine Production (2017-2028)
1.2.3 World Live Attenuated Measles Vaccine Pricing Trends (2017-2028)
1.3 World Live Attenuated Measles Vaccine Production by Region
1.3.1 World Live Attenuated Measles Vaccine Production Value by Region (2017-2028)
1.3.2 World Live Attenuated Measles Vaccine Production by Region (2017-2028)
1.3.3 World Live Attenuated Measles Vaccine Average Price by Region (2017-2028)
1.3.4 North America Live Attenuated Measles Vaccine Production (2017-2028)
1.3.5 Europe Live Attenuated Measles Vaccine Production (2017-2028)
1.3.6 China Live Attenuated Measles Vaccine Production (2017-2028)
1.3.7 Japan Live Attenuated Measles Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Live Attenuated Measles Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Live Attenuated Measles Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Live Attenuated Measles Vaccine Demand (2017-2028)
2.2 World Live Attenuated Measles Vaccine Consumption by Region
2.2.1 World Live Attenuated Measles Vaccine Consumption by Region (2017-2022)
2.2.2 World Live Attenuated Measles Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Live Attenuated Measles Vaccine Consumption (2017-2028)
2.4 China Live Attenuated Measles Vaccine Consumption (2017-2028)
2.5 Europe Live Attenuated Measles Vaccine Consumption (2017-2028)
2.6 Japan Live Attenuated Measles Vaccine Consumption (2017-2028)
2.7 South Korea Live Attenuated Measles Vaccine Consumption (2017-2028)
2.8 ASEAN Live Attenuated Measles Vaccine Consumption (2017-2028)
2.9 India Live Attenuated Measles Vaccine Consumption (2017-2028)
3 WORLD LIVE ATTENUATED MEASLES VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Live Attenuated Measles Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Live Attenuated Measles Vaccine Production by Manufacturer (2017-2022)
3.3 World Live Attenuated Measles Vaccine Average Price by Manufacturer (2017-2022)
3.4 Live Attenuated Measles Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Live Attenuated Measles Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Live Attenuated Measles Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Live Attenuated Measles Vaccine in 2021
3.6 Live Attenuated Measles Vaccine Market: Overall Company Footprint Analysis
3.6.1 Live Attenuated Measles Vaccine Market: Region Footprint
3.6.2 Live Attenuated Measles Vaccine Market: Company Product Type Footprint
3.6.3 Live Attenuated Measles Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Live Attenuated Measles Vaccine Production Value Comparison
4.1.1 United States VS China: Live Attenuated Measles Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Live Attenuated Measles Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Live Attenuated Measles Vaccine Production Comparison
4.2.1 United States VS China: Live Attenuated Measles Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Live Attenuated Measles Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Live Attenuated Measles Vaccine Consumption Comparison
4.3.1 United States VS China: Live Attenuated Measles Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Live Attenuated Measles Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Live Attenuated Measles Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Live Attenuated Measles Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Live Attenuated Measles Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Live Attenuated Measles Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Live Attenuated Measles Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Live Attenuated Measles Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Live Attenuated Measles Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Liquid
5.2.2 Powder
5.3 Market Segment by Type
5.3.1 World Live Attenuated Measles Vaccine Production by Type (2017-2028)
5.3.2 World Live Attenuated Measles Vaccine Production Value by Type (2017-2028)
5.3.3 World Live Attenuated Measles Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Live Attenuated Measles Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Live Attenuated Measles Vaccine Production by Application (2017-2028)
6.3.2 World Live Attenuated Measles Vaccine Production Value by Application (2017-2028)
6.3.3 World Live Attenuated Measles Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Details
7.1.2 GSK Major Business
7.1.3 GSK Live Attenuated Measles Vaccine Product and Services
7.1.4 GSK Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GSK Recent Developments/Updates
7.1.6 GSK Competitive Strengths & Weaknesses
7.2 Sanofi-Pasteur
7.2.1 Sanofi-Pasteur Details
7.2.2 Sanofi-Pasteur Major Business
7.2.3 Sanofi-Pasteur Live Attenuated Measles Vaccine Product and Services
7.2.4 Sanofi-Pasteur Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Sanofi-Pasteur Recent Developments/Updates
7.2.6 Sanofi-Pasteur Competitive Strengths & Weaknesses
7.3 Merck
7.3.1 Merck Details
7.3.2 Merck Major Business
7.3.3 Merck Live Attenuated Measles Vaccine Product and Services
7.3.4 Merck Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Merck Recent Developments/Updates
7.3.6 Merck Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Live Attenuated Measles Vaccine Product and Services
7.4.4 Pfizer Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Serum Institute of India
7.5.1 Serum Institute of India Details
7.5.2 Serum Institute of India Major Business
7.5.3 Serum Institute of India Live Attenuated Measles Vaccine Product and Services
7.5.4 Serum Institute of India Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Serum Institute of India Recent Developments/Updates
7.5.6 Serum Institute of India Competitive Strengths & Weaknesses
7.6 Novartis
7.6.1 Novartis Details
7.6.2 Novartis Major Business
7.6.3 Novartis Live Attenuated Measles Vaccine Product and Services
7.6.4 Novartis Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Novartis Recent Developments/Updates
7.6.6 Novartis Competitive Strengths & Weaknesses
7.7 Emergent Biosolutions
7.7.1 Emergent Biosolutions Details
7.7.2 Emergent Biosolutions Major Business
7.7.3 Emergent Biosolutions Live Attenuated Measles Vaccine Product and Services
7.7.4 Emergent Biosolutions Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Emergent Biosolutions Recent Developments/Updates
7.7.6 Emergent Biosolutions Competitive Strengths & Weaknesses
7.8 Bavarian Nordic
7.8.1 Bavarian Nordic Details
7.8.2 Bavarian Nordic Major Business
7.8.3 Bavarian Nordic Live Attenuated Measles Vaccine Product and Services
7.8.4 Bavarian Nordic Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bavarian Nordic Recent Developments/Updates
7.8.6 Bavarian Nordic Competitive Strengths & Weaknesses
7.9 Medimmune
7.9.1 Medimmune Details
7.9.2 Medimmune Major Business
7.9.3 Medimmune Live Attenuated Measles Vaccine Product and Services
7.9.4 Medimmune Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Medimmune Recent Developments/Updates
7.9.6 Medimmune Competitive Strengths & Weaknesses
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Details
7.10.2 Johnson & Johnson Major Business
7.10.3 Johnson & Johnson Live Attenuated Measles Vaccine Product and Services
7.10.4 Johnson & Johnson Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Johnson & Johnson Recent Developments/Updates
7.10.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.11 CSL Limited
7.11.1 CSL Limited Details
7.11.2 CSL Limited Major Business
7.11.3 CSL Limited Live Attenuated Measles Vaccine Product and Services
7.11.4 CSL Limited Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 CSL Limited Recent Developments/Updates
7.11.6 CSL Limited Competitive Strengths & Weaknesses
7.12 Changchun Qijian Biological Products Co., Ltd
7.12.1 Changchun Qijian Biological Products Co., Ltd Details
7.12.2 Changchun Qijian Biological Products Co., Ltd Major Business
7.12.3 Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
7.12.4 Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Changchun Qijian Biological Products Co., Ltd Recent Developments/Updates
7.12.6 Changchun Qijian Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.13 Beijing Institute of Biological Products Co., Ltd
7.13.1 Beijing Institute of Biological Products Co., Ltd Details
7.13.2 Beijing Institute of Biological Products Co., Ltd Major Business
7.13.3 Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
7.13.4 Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
7.13.6 Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.14 Wuhan Institute of Biological Products Co., Ltd
7.14.1 Wuhan Institute of Biological Products Co., Ltd Details
7.14.2 Wuhan Institute of Biological Products Co., Ltd Major Business
7.14.3 Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
7.14.4 Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Wuhan Institute of Biological Products Co., Ltd Recent Developments/Updates
7.14.6 Wuhan Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.15 Shanghai Institute of Biological Products Co., Ltd
7.15.1 Shanghai Institute of Biological Products Co., Ltd Details
7.15.2 Shanghai Institute of Biological Products Co., Ltd Major Business
7.15.3 Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
7.15.4 Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Shanghai Institute of Biological Products Co., Ltd Recent Developments/Updates
7.15.6 Shanghai Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.16 Lanzhou Institute of Biological Products Co., Ltd
7.16.1 Lanzhou Institute of Biological Products Co., Ltd Details
7.16.2 Lanzhou Institute of Biological Products Co., Ltd Major Business
7.16.3 Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
7.16.4 Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
7.16.6 Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Live Attenuated Measles Vaccine and Key Manufacturers
8.2 Live Attenuated Measles Vaccine Manufacturing Costs
8.3 Live Attenuated Measles Vaccine Production Process
8.4 Live Attenuated Measles Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Live Attenuated Measles Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Live Attenuated Measles Vaccine Typical Distributors
9.3 Live Attenuated Measles Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Live Attenuated Measles Vaccine Introduction
1.2 World Live Attenuated Measles Vaccine Supply & Forecast
1.2.1 World Live Attenuated Measles Vaccine Production Value (2017 & 2021 & 2028)
1.2.2 World Live Attenuated Measles Vaccine Production (2017-2028)
1.2.3 World Live Attenuated Measles Vaccine Pricing Trends (2017-2028)
1.3 World Live Attenuated Measles Vaccine Production by Region
1.3.1 World Live Attenuated Measles Vaccine Production Value by Region (2017-2028)
1.3.2 World Live Attenuated Measles Vaccine Production by Region (2017-2028)
1.3.3 World Live Attenuated Measles Vaccine Average Price by Region (2017-2028)
1.3.4 North America Live Attenuated Measles Vaccine Production (2017-2028)
1.3.5 Europe Live Attenuated Measles Vaccine Production (2017-2028)
1.3.6 China Live Attenuated Measles Vaccine Production (2017-2028)
1.3.7 Japan Live Attenuated Measles Vaccine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Live Attenuated Measles Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Live Attenuated Measles Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Live Attenuated Measles Vaccine Demand (2017-2028)
2.2 World Live Attenuated Measles Vaccine Consumption by Region
2.2.1 World Live Attenuated Measles Vaccine Consumption by Region (2017-2022)
2.2.2 World Live Attenuated Measles Vaccine Consumption Forecast by Region (2023-2028)
2.3 United States Live Attenuated Measles Vaccine Consumption (2017-2028)
2.4 China Live Attenuated Measles Vaccine Consumption (2017-2028)
2.5 Europe Live Attenuated Measles Vaccine Consumption (2017-2028)
2.6 Japan Live Attenuated Measles Vaccine Consumption (2017-2028)
2.7 South Korea Live Attenuated Measles Vaccine Consumption (2017-2028)
2.8 ASEAN Live Attenuated Measles Vaccine Consumption (2017-2028)
2.9 India Live Attenuated Measles Vaccine Consumption (2017-2028)
3 WORLD LIVE ATTENUATED MEASLES VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Live Attenuated Measles Vaccine Production Value by Manufacturer (2017-2022)
3.2 World Live Attenuated Measles Vaccine Production by Manufacturer (2017-2022)
3.3 World Live Attenuated Measles Vaccine Average Price by Manufacturer (2017-2022)
3.4 Live Attenuated Measles Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Live Attenuated Measles Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Live Attenuated Measles Vaccine in 2021
3.5.3 Global Concentration Ratios (CR8) for Live Attenuated Measles Vaccine in 2021
3.6 Live Attenuated Measles Vaccine Market: Overall Company Footprint Analysis
3.6.1 Live Attenuated Measles Vaccine Market: Region Footprint
3.6.2 Live Attenuated Measles Vaccine Market: Company Product Type Footprint
3.6.3 Live Attenuated Measles Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Live Attenuated Measles Vaccine Production Value Comparison
4.1.1 United States VS China: Live Attenuated Measles Vaccine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Live Attenuated Measles Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Live Attenuated Measles Vaccine Production Comparison
4.2.1 United States VS China: Live Attenuated Measles Vaccine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Live Attenuated Measles Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Live Attenuated Measles Vaccine Consumption Comparison
4.3.1 United States VS China: Live Attenuated Measles Vaccine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Live Attenuated Measles Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Live Attenuated Measles Vaccine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Live Attenuated Measles Vaccine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022)
4.5 China Live Attenuated Measles Vaccine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Live Attenuated Measles Vaccine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Live Attenuated Measles Vaccine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Live Attenuated Measles Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Live Attenuated Measles Vaccine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Liquid
5.2.2 Powder
5.3 Market Segment by Type
5.3.1 World Live Attenuated Measles Vaccine Production by Type (2017-2028)
5.3.2 World Live Attenuated Measles Vaccine Production Value by Type (2017-2028)
5.3.3 World Live Attenuated Measles Vaccine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Live Attenuated Measles Vaccine Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Live Attenuated Measles Vaccine Production by Application (2017-2028)
6.3.2 World Live Attenuated Measles Vaccine Production Value by Application (2017-2028)
6.3.3 World Live Attenuated Measles Vaccine Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Details
7.1.2 GSK Major Business
7.1.3 GSK Live Attenuated Measles Vaccine Product and Services
7.1.4 GSK Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GSK Recent Developments/Updates
7.1.6 GSK Competitive Strengths & Weaknesses
7.2 Sanofi-Pasteur
7.2.1 Sanofi-Pasteur Details
7.2.2 Sanofi-Pasteur Major Business
7.2.3 Sanofi-Pasteur Live Attenuated Measles Vaccine Product and Services
7.2.4 Sanofi-Pasteur Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Sanofi-Pasteur Recent Developments/Updates
7.2.6 Sanofi-Pasteur Competitive Strengths & Weaknesses
7.3 Merck
7.3.1 Merck Details
7.3.2 Merck Major Business
7.3.3 Merck Live Attenuated Measles Vaccine Product and Services
7.3.4 Merck Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Merck Recent Developments/Updates
7.3.6 Merck Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Live Attenuated Measles Vaccine Product and Services
7.4.4 Pfizer Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Serum Institute of India
7.5.1 Serum Institute of India Details
7.5.2 Serum Institute of India Major Business
7.5.3 Serum Institute of India Live Attenuated Measles Vaccine Product and Services
7.5.4 Serum Institute of India Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Serum Institute of India Recent Developments/Updates
7.5.6 Serum Institute of India Competitive Strengths & Weaknesses
7.6 Novartis
7.6.1 Novartis Details
7.6.2 Novartis Major Business
7.6.3 Novartis Live Attenuated Measles Vaccine Product and Services
7.6.4 Novartis Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Novartis Recent Developments/Updates
7.6.6 Novartis Competitive Strengths & Weaknesses
7.7 Emergent Biosolutions
7.7.1 Emergent Biosolutions Details
7.7.2 Emergent Biosolutions Major Business
7.7.3 Emergent Biosolutions Live Attenuated Measles Vaccine Product and Services
7.7.4 Emergent Biosolutions Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Emergent Biosolutions Recent Developments/Updates
7.7.6 Emergent Biosolutions Competitive Strengths & Weaknesses
7.8 Bavarian Nordic
7.8.1 Bavarian Nordic Details
7.8.2 Bavarian Nordic Major Business
7.8.3 Bavarian Nordic Live Attenuated Measles Vaccine Product and Services
7.8.4 Bavarian Nordic Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Bavarian Nordic Recent Developments/Updates
7.8.6 Bavarian Nordic Competitive Strengths & Weaknesses
7.9 Medimmune
7.9.1 Medimmune Details
7.9.2 Medimmune Major Business
7.9.3 Medimmune Live Attenuated Measles Vaccine Product and Services
7.9.4 Medimmune Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Medimmune Recent Developments/Updates
7.9.6 Medimmune Competitive Strengths & Weaknesses
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Details
7.10.2 Johnson & Johnson Major Business
7.10.3 Johnson & Johnson Live Attenuated Measles Vaccine Product and Services
7.10.4 Johnson & Johnson Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Johnson & Johnson Recent Developments/Updates
7.10.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.11 CSL Limited
7.11.1 CSL Limited Details
7.11.2 CSL Limited Major Business
7.11.3 CSL Limited Live Attenuated Measles Vaccine Product and Services
7.11.4 CSL Limited Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 CSL Limited Recent Developments/Updates
7.11.6 CSL Limited Competitive Strengths & Weaknesses
7.12 Changchun Qijian Biological Products Co., Ltd
7.12.1 Changchun Qijian Biological Products Co., Ltd Details
7.12.2 Changchun Qijian Biological Products Co., Ltd Major Business
7.12.3 Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
7.12.4 Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Changchun Qijian Biological Products Co., Ltd Recent Developments/Updates
7.12.6 Changchun Qijian Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.13 Beijing Institute of Biological Products Co., Ltd
7.13.1 Beijing Institute of Biological Products Co., Ltd Details
7.13.2 Beijing Institute of Biological Products Co., Ltd Major Business
7.13.3 Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
7.13.4 Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
7.13.6 Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.14 Wuhan Institute of Biological Products Co., Ltd
7.14.1 Wuhan Institute of Biological Products Co., Ltd Details
7.14.2 Wuhan Institute of Biological Products Co., Ltd Major Business
7.14.3 Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
7.14.4 Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Wuhan Institute of Biological Products Co., Ltd Recent Developments/Updates
7.14.6 Wuhan Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.15 Shanghai Institute of Biological Products Co., Ltd
7.15.1 Shanghai Institute of Biological Products Co., Ltd Details
7.15.2 Shanghai Institute of Biological Products Co., Ltd Major Business
7.15.3 Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
7.15.4 Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Shanghai Institute of Biological Products Co., Ltd Recent Developments/Updates
7.15.6 Shanghai Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
7.16 Lanzhou Institute of Biological Products Co., Ltd
7.16.1 Lanzhou Institute of Biological Products Co., Ltd Details
7.16.2 Lanzhou Institute of Biological Products Co., Ltd Major Business
7.16.3 Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
7.16.4 Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments/Updates
7.16.6 Lanzhou Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Live Attenuated Measles Vaccine and Key Manufacturers
8.2 Live Attenuated Measles Vaccine Manufacturing Costs
8.3 Live Attenuated Measles Vaccine Production Process
8.4 Live Attenuated Measles Vaccine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Live Attenuated Measles Vaccine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Live Attenuated Measles Vaccine Typical Distributors
9.3 Live Attenuated Measles Vaccine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Live Attenuated Measles Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Live Attenuated Measles Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Live Attenuated Measles Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Live Attenuated Measles Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Live Attenuated Measles Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Live Attenuated Measles Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Live Attenuated Measles Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Live Attenuated Measles Vaccine Production Market Share by Region (2017-2022)
Table 9. World Live Attenuated Measles Vaccine Production Market Share by Region (2023-2028)
Table 10. World Live Attenuated Measles Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Live Attenuated Measles Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Live Attenuated Measles Vaccine Major Market Trends
Table 13. World Live Attenuated Measles Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Live Attenuated Measles Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Live Attenuated Measles Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Live Attenuated Measles Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Live Attenuated Measles Vaccine Producers in 2021
Table 18. World Live Attenuated Measles Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Live Attenuated Measles Vaccine Producers in 2021
Table 20. World Live Attenuated Measles Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Live Attenuated Measles Vaccine Company Evaluation Quadrant
Table 22. World Live Attenuated Measles Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Live Attenuated Measles Vaccine Production Site of Key Manufacturer
Table 24. Live Attenuated Measles Vaccine Market: Company Product Type Footprint
Table 25. Live Attenuated Measles Vaccine Market: Company Product Application Footprint
Table 26. Live Attenuated Measles Vaccine Competitive Factors
Table 27. Live Attenuated Measles Vaccine New Entrant and Capacity Expansion Plans
Table 28. Live Attenuated Measles Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Live Attenuated Measles Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Live Attenuated Measles Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Live Attenuated Measles Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Live Attenuated Measles Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Live Attenuated Measles Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Live Attenuated Measles Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Live Attenuated Measles Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Live Attenuated Measles Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Live Attenuated Measles Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Live Attenuated Measles Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Live Attenuated Measles Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Live Attenuated Measles Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Live Attenuated Measles Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Live Attenuated Measles Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Live Attenuated Measles Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Live Attenuated Measles Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Live Attenuated Measles Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Live Attenuated Measles Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Live Attenuated Measles Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Live Attenuated Measles Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Live Attenuated Measles Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Live Attenuated Measles Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Live Attenuated Measles Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Live Attenuated Measles Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Live Attenuated Measles Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Live Attenuated Measles Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GSK Basic Information, Manufacturing Base and Competitors
Table 62. GSK Major Business
Table 63. GSK Live Attenuated Measles Vaccine Product and Services
Table 64. GSK Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GSK Recent Developments/Updates
Table 66. GSK Competitive Strengths & Weaknesses
Table 67. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi-Pasteur Major Business
Table 69. Sanofi-Pasteur Live Attenuated Measles Vaccine Product and Services
Table 70. Sanofi-Pasteur Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Sanofi-Pasteur Recent Developments/Updates
Table 72. Sanofi-Pasteur Competitive Strengths & Weaknesses
Table 73. Merck Basic Information, Manufacturing Base and Competitors
Table 74. Merck Major Business
Table 75. Merck Live Attenuated Measles Vaccine Product and Services
Table 76. Merck Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Merck Recent Developments/Updates
Table 78. Merck Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Live Attenuated Measles Vaccine Product and Services
Table 82. Pfizer Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 86. Serum Institute of India Major Business
Table 87. Serum Institute of India Live Attenuated Measles Vaccine Product and Services
Table 88. Serum Institute of India Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Serum Institute of India Recent Developments/Updates
Table 90. Serum Institute of India Competitive Strengths & Weaknesses
Table 91. Novartis Basic Information, Manufacturing Base and Competitors
Table 92. Novartis Major Business
Table 93. Novartis Live Attenuated Measles Vaccine Product and Services
Table 94. Novartis Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Novartis Recent Developments/Updates
Table 96. Novartis Competitive Strengths & Weaknesses
Table 97. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 98. Emergent Biosolutions Major Business
Table 99. Emergent Biosolutions Live Attenuated Measles Vaccine Product and Services
Table 100. Emergent Biosolutions Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Emergent Biosolutions Recent Developments/Updates
Table 102. Emergent Biosolutions Competitive Strengths & Weaknesses
Table 103. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 104. Bavarian Nordic Major Business
Table 105. Bavarian Nordic Live Attenuated Measles Vaccine Product and Services
Table 106. Bavarian Nordic Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bavarian Nordic Recent Developments/Updates
Table 108. Bavarian Nordic Competitive Strengths & Weaknesses
Table 109. Medimmune Basic Information, Manufacturing Base and Competitors
Table 110. Medimmune Major Business
Table 111. Medimmune Live Attenuated Measles Vaccine Product and Services
Table 112. Medimmune Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Medimmune Recent Developments/Updates
Table 114. Medimmune Competitive Strengths & Weaknesses
Table 115. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 116. Johnson & Johnson Major Business
Table 117. Johnson & Johnson Live Attenuated Measles Vaccine Product and Services
Table 118. Johnson & Johnson Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Johnson & Johnson Recent Developments/Updates
Table 120. Johnson & Johnson Competitive Strengths & Weaknesses
Table 121. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 122. CSL Limited Major Business
Table 123. CSL Limited Live Attenuated Measles Vaccine Product and Services
Table 124. CSL Limited Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. CSL Limited Recent Developments/Updates
Table 126. CSL Limited Competitive Strengths & Weaknesses
Table 127. Changchun Qijian Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Changchun Qijian Biological Products Co., Ltd Major Business
Table 129. Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
Table 130. Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Changchun Qijian Biological Products Co., Ltd Recent Developments/Updates
Table 132. Changchun Qijian Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 133. Beijing Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Beijing Institute of Biological Products Co., Ltd Major Business
Table 135. Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
Table 136. Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 138. Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 139. Wuhan Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Wuhan Institute of Biological Products Co., Ltd Major Business
Table 141. Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
Table 142. Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Wuhan Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 144. Wuhan Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 145. Shanghai Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Shanghai Institute of Biological Products Co., Ltd Major Business
Table 147. Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
Table 148. Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Shanghai Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 150. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 151. Lanzhou Institute of Biological Products Co., Ltd Major Business
Table 152. Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
Table 153. Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 154. Live Attenuated Measles Vaccine Raw Material
Table 155. Key Manufacturers of Live Attenuated Measles Vaccine Raw Materials
Table 156. Live Attenuated Measles Vaccine Typical Distributors
Table 157. Live Attenuated Measles Vaccine Typical Customers
Table 1. World Live Attenuated Measles Vaccine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Live Attenuated Measles Vaccine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Live Attenuated Measles Vaccine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Live Attenuated Measles Vaccine Production Value Market Share by Region (2017-2022)
Table 5. World Live Attenuated Measles Vaccine Production Value Market Share by Region (2023-2028)
Table 6. World Live Attenuated Measles Vaccine Production by Region (2017-2022) & (K Units)
Table 7. World Live Attenuated Measles Vaccine Production by Region (2023-2028) & (K Units)
Table 8. World Live Attenuated Measles Vaccine Production Market Share by Region (2017-2022)
Table 9. World Live Attenuated Measles Vaccine Production Market Share by Region (2023-2028)
Table 10. World Live Attenuated Measles Vaccine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Live Attenuated Measles Vaccine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Live Attenuated Measles Vaccine Major Market Trends
Table 13. World Live Attenuated Measles Vaccine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Live Attenuated Measles Vaccine Consumption by Region (2017-2022) & (K Units)
Table 15. World Live Attenuated Measles Vaccine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Live Attenuated Measles Vaccine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Live Attenuated Measles Vaccine Producers in 2021
Table 18. World Live Attenuated Measles Vaccine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Live Attenuated Measles Vaccine Producers in 2021
Table 20. World Live Attenuated Measles Vaccine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Live Attenuated Measles Vaccine Company Evaluation Quadrant
Table 22. World Live Attenuated Measles Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Live Attenuated Measles Vaccine Production Site of Key Manufacturer
Table 24. Live Attenuated Measles Vaccine Market: Company Product Type Footprint
Table 25. Live Attenuated Measles Vaccine Market: Company Product Application Footprint
Table 26. Live Attenuated Measles Vaccine Competitive Factors
Table 27. Live Attenuated Measles Vaccine New Entrant and Capacity Expansion Plans
Table 28. Live Attenuated Measles Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Live Attenuated Measles Vaccine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Live Attenuated Measles Vaccine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Live Attenuated Measles Vaccine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Live Attenuated Measles Vaccine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Live Attenuated Measles Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Live Attenuated Measles Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Live Attenuated Measles Vaccine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Live Attenuated Measles Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Live Attenuated Measles Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Live Attenuated Measles Vaccine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Live Attenuated Measles Vaccine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Live Attenuated Measles Vaccine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Live Attenuated Measles Vaccine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Live Attenuated Measles Vaccine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Live Attenuated Measles Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Live Attenuated Measles Vaccine Production by Type (2017-2022) & (K Units)
Table 49. World Live Attenuated Measles Vaccine Production by Type (2023-2028) & (K Units)
Table 50. World Live Attenuated Measles Vaccine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Live Attenuated Measles Vaccine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Live Attenuated Measles Vaccine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Live Attenuated Measles Vaccine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Live Attenuated Measles Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Live Attenuated Measles Vaccine Production by Application (2017-2022) & (K Units)
Table 56. World Live Attenuated Measles Vaccine Production by Application (2023-2028) & (K Units)
Table 57. World Live Attenuated Measles Vaccine Production Value by Application (2017-2022) & (USD Million)
Table 58. World Live Attenuated Measles Vaccine Production Value by Application (2023-2028) & (USD Million)
Table 59. World Live Attenuated Measles Vaccine Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Live Attenuated Measles Vaccine Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GSK Basic Information, Manufacturing Base and Competitors
Table 62. GSK Major Business
Table 63. GSK Live Attenuated Measles Vaccine Product and Services
Table 64. GSK Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GSK Recent Developments/Updates
Table 66. GSK Competitive Strengths & Weaknesses
Table 67. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi-Pasteur Major Business
Table 69. Sanofi-Pasteur Live Attenuated Measles Vaccine Product and Services
Table 70. Sanofi-Pasteur Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Sanofi-Pasteur Recent Developments/Updates
Table 72. Sanofi-Pasteur Competitive Strengths & Weaknesses
Table 73. Merck Basic Information, Manufacturing Base and Competitors
Table 74. Merck Major Business
Table 75. Merck Live Attenuated Measles Vaccine Product and Services
Table 76. Merck Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Merck Recent Developments/Updates
Table 78. Merck Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Live Attenuated Measles Vaccine Product and Services
Table 82. Pfizer Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 86. Serum Institute of India Major Business
Table 87. Serum Institute of India Live Attenuated Measles Vaccine Product and Services
Table 88. Serum Institute of India Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Serum Institute of India Recent Developments/Updates
Table 90. Serum Institute of India Competitive Strengths & Weaknesses
Table 91. Novartis Basic Information, Manufacturing Base and Competitors
Table 92. Novartis Major Business
Table 93. Novartis Live Attenuated Measles Vaccine Product and Services
Table 94. Novartis Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Novartis Recent Developments/Updates
Table 96. Novartis Competitive Strengths & Weaknesses
Table 97. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 98. Emergent Biosolutions Major Business
Table 99. Emergent Biosolutions Live Attenuated Measles Vaccine Product and Services
Table 100. Emergent Biosolutions Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Emergent Biosolutions Recent Developments/Updates
Table 102. Emergent Biosolutions Competitive Strengths & Weaknesses
Table 103. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 104. Bavarian Nordic Major Business
Table 105. Bavarian Nordic Live Attenuated Measles Vaccine Product and Services
Table 106. Bavarian Nordic Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Bavarian Nordic Recent Developments/Updates
Table 108. Bavarian Nordic Competitive Strengths & Weaknesses
Table 109. Medimmune Basic Information, Manufacturing Base and Competitors
Table 110. Medimmune Major Business
Table 111. Medimmune Live Attenuated Measles Vaccine Product and Services
Table 112. Medimmune Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Medimmune Recent Developments/Updates
Table 114. Medimmune Competitive Strengths & Weaknesses
Table 115. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 116. Johnson & Johnson Major Business
Table 117. Johnson & Johnson Live Attenuated Measles Vaccine Product and Services
Table 118. Johnson & Johnson Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Johnson & Johnson Recent Developments/Updates
Table 120. Johnson & Johnson Competitive Strengths & Weaknesses
Table 121. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 122. CSL Limited Major Business
Table 123. CSL Limited Live Attenuated Measles Vaccine Product and Services
Table 124. CSL Limited Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. CSL Limited Recent Developments/Updates
Table 126. CSL Limited Competitive Strengths & Weaknesses
Table 127. Changchun Qijian Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 128. Changchun Qijian Biological Products Co., Ltd Major Business
Table 129. Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
Table 130. Changchun Qijian Biological Products Co., Ltd Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Changchun Qijian Biological Products Co., Ltd Recent Developments/Updates
Table 132. Changchun Qijian Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 133. Beijing Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 134. Beijing Institute of Biological Products Co., Ltd Major Business
Table 135. Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
Table 136. Beijing Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Beijing Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 138. Beijing Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 139. Wuhan Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 140. Wuhan Institute of Biological Products Co., Ltd Major Business
Table 141. Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
Table 142. Wuhan Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Wuhan Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 144. Wuhan Institute of Biological Products Co., Ltd Competitive Strengths & Weaknesses
Table 145. Shanghai Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 146. Shanghai Institute of Biological Products Co., Ltd Major Business
Table 147. Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
Table 148. Shanghai Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Shanghai Institute of Biological Products Co., Ltd Recent Developments/Updates
Table 150. Lanzhou Institute of Biological Products Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 151. Lanzhou Institute of Biological Products Co., Ltd Major Business
Table 152. Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Product and Services
Table 153. Lanzhou Institute of Biological Products Co., Ltd Live Attenuated Measles Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 154. Live Attenuated Measles Vaccine Raw Material
Table 155. Key Manufacturers of Live Attenuated Measles Vaccine Raw Materials
Table 156. Live Attenuated Measles Vaccine Typical Distributors
Table 157. Live Attenuated Measles Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Live Attenuated Measles Vaccine Picture
Figure 2. World Live Attenuated Measles Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Live Attenuated Measles Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Live Attenuated Measles Vaccine Production (2017-2028) & (K Units)
Figure 5. World Live Attenuated Measles Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Live Attenuated Measles Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Live Attenuated Measles Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Live Attenuated Measles Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Live Attenuated Measles Vaccine Production (2017-2028) & (K Units)
Figure 10. China Live Attenuated Measles Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Live Attenuated Measles Vaccine Production (2017-2028) & (K Units)
Figure 12. Live Attenuated Measles Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Live Attenuated Measles Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Live Attenuated Measles Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Live Attenuated Measles Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Live Attenuated Measles Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Live Attenuated Measles Vaccine Markets in 2021
Figure 26. United States VS China: Live Attenuated Measles Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Live Attenuated Measles Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Live Attenuated Measles Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Live Attenuated Measles Vaccine in United States
Figure 30. Key Producers and Market Share of Live Attenuated Measles Vaccine in China
Figure 31. Key Producers and Market Share of Live Attenuated Measles Vaccine in Rest of World
Figure 32. World Live Attenuated Measles Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Live Attenuated Measles Vaccine Production Value Market Share by Type in 2021
Figure 34. Liquid
Figure 35. Powder
Figure 36. World Live Attenuated Measles Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Live Attenuated Measles Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Live Attenuated Measles Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Live Attenuated Measles Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Live Attenuated Measles Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Live Attenuated Measles Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Live Attenuated Measles Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Live Attenuated Measles Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Live Attenuated Measles Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Live Attenuated Measles Vaccine
Figure 48. Live Attenuated Measles Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Live Attenuated Measles Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Live Attenuated Measles Vaccine Picture
Figure 2. World Live Attenuated Measles Vaccine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Live Attenuated Measles Vaccine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Live Attenuated Measles Vaccine Production (2017-2028) & (K Units)
Figure 5. World Live Attenuated Measles Vaccine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Live Attenuated Measles Vaccine Production Value Market Share by Region (2017-2028)
Figure 7. World Live Attenuated Measles Vaccine Production Market Share by Region (2017-2028)
Figure 8. North America Live Attenuated Measles Vaccine Production (2017-2028) & (K Units)
Figure 9. Europe Live Attenuated Measles Vaccine Production (2017-2028) & (K Units)
Figure 10. China Live Attenuated Measles Vaccine Production (2017-2028) & (K Units)
Figure 11. Japan Live Attenuated Measles Vaccine Production (2017-2028) & (K Units)
Figure 12. Live Attenuated Measles Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Live Attenuated Measles Vaccine Demand (2017-2028) & (K Units)
Figure 15. World Live Attenuated Measles Vaccine Consumption Market Share by Region (2017-2028)
Figure 16. United States Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 17. China Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 18. Europe Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 19. Japan Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 22. India Live Attenuated Measles Vaccine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Live Attenuated Measles Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Live Attenuated Measles Vaccine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Live Attenuated Measles Vaccine Markets in 2021
Figure 26. United States VS China: Live Attenuated Measles Vaccine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Live Attenuated Measles Vaccine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Live Attenuated Measles Vaccine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Live Attenuated Measles Vaccine in United States
Figure 30. Key Producers and Market Share of Live Attenuated Measles Vaccine in China
Figure 31. Key Producers and Market Share of Live Attenuated Measles Vaccine in Rest of World
Figure 32. World Live Attenuated Measles Vaccine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Live Attenuated Measles Vaccine Production Value Market Share by Type in 2021
Figure 34. Liquid
Figure 35. Powder
Figure 36. World Live Attenuated Measles Vaccine Production Market Share by Type (2017-2028)
Figure 37. World Live Attenuated Measles Vaccine Production Value Market Share by Type (2017-2028)
Figure 38. World Live Attenuated Measles Vaccine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Live Attenuated Measles Vaccine Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Live Attenuated Measles Vaccine Production Value Market Share by Application in 2021
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Live Attenuated Measles Vaccine Production Market Share by Application (2017-2028)
Figure 44. World Live Attenuated Measles Vaccine Production Value Market Share by Application (2017-2028)
Figure 45. World Live Attenuated Measles Vaccine Average Price by Application (2017-2028) & (US$/Unit)
Figure 46. Manufacturing Cost Structure Analysis of Live Attenuated Measles Vaccine in 2021
Figure 47. Manufacturing Process Analysis of Live Attenuated Measles Vaccine
Figure 48. Live Attenuated Measles Vaccine Industrial Chain
Figure 49. Distribution Channel Breakdown for Live Attenuated Measles Vaccine Shipments (%): 2017-2028
Figure 50. Direct Channel Pros & Cons
Figure 51. Indirect Channel Pros & Cons
Figure 52. Methodology
Figure 53. Research Process and Data Source
